BeyondSpring Inc. (NASDAQ:BYSI – Get Free Report) fell 1% on Tuesday . The stock traded as low as $2.12 and last traded at $2.12. 16,276 shares changed hands during mid-day trading, a decline of 82% from the average session volume of 91,642 shares. The stock had previously closed at $2.14.
BeyondSpring Stock Down 3.5 %
The firm has a 50 day moving average price of $2.21 and a two-hundred day moving average price of $2.28.
Hedge Funds Weigh In On BeyondSpring
An institutional investor recently bought a new position in BeyondSpring stock. SG Americas Securities LLC bought a new stake in shares of BeyondSpring Inc. (NASDAQ:BYSI – Free Report) during the 1st quarter, according to its most recent filing with the SEC. The firm bought 17,539 shares of the company’s stock, valued at approximately $63,000. Institutional investors own 40.29% of the company’s stock.
BeyondSpring Company Profile
BeyondSpring Inc, a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immunomodulating microtubule-binding agent that has completed Phase III clinical trials for treatment of non-small cell lung cancer (NSCLC); and as an anti-cancer agent, as well as for the prevention of chemotherapy-induced neutropenia.
Featured Articles
- Five stocks we like better than BeyondSpring
- Russell 2000 Index, How Investors Use it For Profitable Trading
- Gilead’s Stock Surge: What’s Fueling the Momentum?
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- Breakout Alert: Qualcomm Just Hit The Rally Button
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- Mercado Libre Shares Go on Sale: Is Now the Time to Buy?
Receive News & Ratings for BeyondSpring Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BeyondSpring and related companies with MarketBeat.com's FREE daily email newsletter.
